Researchers at the European Congress of Obesity released results of a new clinical trial of Wegovy, the weight loss version of Ozempic.drugs can help with heart failure and heart attack. This week at the European Congress of Obesity, researchers released the overall results of the longest clinical trial yet of the drug Wegovy, the weight loss version of Ozempic.
"These medications may have an effect on inflammation, and chronic inflammation can contribute to a lot of health issues," he said. But for shedding pounds, the results show the average body weight reduction of about 10% continued for a year and was more or less sustained for up to four years. As far as safety, there are no surprises. Serious side effects such as gastroparesis were rare. The more common nausea, diarrhea and constipation were reasons why some people stopped taking it. The steep out-of-pocket costs even with insurance are another reason.Ali said people should remember that Wegovy and other similar weight loss drugs are not magic potions - you still have to do the work.